PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20976259-7	2010	Cell lines with truncation, deletion, and null status of p53 were resistant to gemcitabine without apparent relationship to RRM1 levels.	gemcitabine	79-90	tumor protein p53	Homo sapiens	57-60	
20976259-9	2010	The impact of p53 mutations in patients treated with gemcitabine should be studied in prospective clinical trials to develop a model with improved precision of predicting drug efficacy.	gemcitabine	53-64	tumor protein p53	Homo sapiens	14-17